Krebs, Simone http://orcid.org/0000-0002-9909-4531
O’Donoghue, Joseph A.
Biegel, Evan
Beattie, Bradley J.
Reidy, Diane
Lyashchenko, Serge K.
Lewis, Jason S.
Bodei, Lisa
Weber, Wolfgang A.
Pandit-Taskar, Neeta
Funding for this research was provided by:
NIH/NCI (P30 CA008748)
National Cancer Institute (K12 CA184746)
the Clinical and Translational Science Center at Weill Cornell Medical Center and MSK (UL1TR00457)
Geoffrey Beene Cancer Research Center (Geoffrey Beene Cancer Research Center)
Neuroendocrine Tumor Research Foundation (Neuroendocrine Tumor Research Foundation)
NIH (R35 CA232130)
Article History
Received: 18 February 2020
Accepted: 22 April 2020
First Online: 6 May 2020
Compliance with ethical standards
:
: J. A. O’Donoghue is a consultant for Janssen Pharmaceuticals, Inc. D. Reidy is on advisory boards for Novartis, Ipsen and AAA and has received research support from Novartis, Merck, and Ipsen. J. Lewis serves on advisory boards and has received compensation (or stock) from pHLIP, Inc., Clarity Pharmaceuticals, Varian Medical Systems, InVicro, Inc., Evergreen Theragnostics, Inc., Telix Pharmaceuticals Ltd., and Trace-Ability, Inc. He is a consultant for TPG Capital, L.P., and has received research support (financial and/or reagents) from Eli Lilly and Company, Sapience Therapeutics, Inc., Mabvax Therapeutics Holdings Inc., SibTech, Inc., Thermo Fisher Scientific, ImaginAb, Inc. U.S., Merck & Company, Inc., AbbVie Inc., Bristol-Myers Squibb Company, Genentech, Inc., Y-mAbs Therapeutics, Inc., and Regeneron Pharmaceuticals, Inc. L. Bodei is a consultant (unpaid) for AAA, Ipsen, Clovis, and Curium and receives research support from AAA. W. Weber is on advisory boards and receives compensation from Bayer, Blue Earth Diagnostics, Endocyte, Pentixapharm, and ITG. He has received research support from BMS, Imaginab, Ipsen, and Piramal. N. Pandit-Taskar is a consultant, receives honoraria or serves on the advisory board for Actinium Pharma, Progenics, Medimmune/Astrazeneca, and conducted research supported by Imaginab, Genentech, Janssen. S. Krebs, E. Biegel, B.J. Beattie, and S.K. Lyashchenko declare that they have no conflicts of interest.
: All procedures involving human participants were performed in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards.
: Informed written consent was obtained from all individual participants included in the study.
: Not applicable.